Digital Therapeutics in India: From Innovation to Clinical Adoption
Digital therapeutics (DTx) are evidence-based digital interventions aimed at the prevention, treatment or management of diseases using clinically validated approaches. DTx products differ from wellness applications in that their main purpose is to provide medically measurable outcomes through structured interventions such as behavioural modification, digital cognitive therapy, remote monitoring and personalised disease management.
With the rising burden of non-communicable diseases, increasing smartphone use and the development of digital health infrastructure, India represents an attractive market for digital therapeutics. Diabetes, cardiovascular diseases, mental health conditions and stroke-related disabilities require sustained medical management beyond hospital visits. Digital interventions can support ongoing care by helping patients stay connected with healthcare providers, receive tailored guidance and track their health progress remotely.
Unlock the Future of Digital Health — Free for 14 Days!
Join DHN Plus and access exclusive news, intelligence reports, and deep-dive research trusted by healthtech leaders.
Already a subscriber? Log in
Start with 14-Days Free TrialStay tuned for more such updates on Digital Health News